This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

REPORT OF A CASE

MERVIN E. GREEN, M.D.; JAMES S. SNOW, M.D.

Arch Intern Med. 1939;64(3):579-585.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The ability of the thiocyanates to lower the blood pressure was observed as early as 1903 by Pauli,¹ but the drugs were not introduced in the treatment of hypertension until 1924, by Westphal.² Their use has been limited, however, because of the toxic effects frequently produced. In 1932 Goldring and Chasis³ reported the toxic symptoms which occurred in 13 of 50 patients treated for hypertension with thiocyanate. These symptoms consisted of muscular fatigue, nausea and vomiting, mental confusion, hallucinations and motor aphasia. They also reported 2 deaths, preceded by delirium, convulsive twitchings and coma. They pointed out that some persons show a distinct susceptibility to the drug.

In 1926 Takacs⁴ reported the first case of dermatitis due to thiocyanate. This was a papular eruption which occurred after the ingestion of 1 Gm. of potassium thiocyanate daily for nine days. Since that time there have been reported numerous cases of mild . . . [Full Text PDF of this Article]

Author Affiliations
Assistant Resident in Internal Medicine; Research Associate in Dermatology and Syphilology ANN ARBOR, MICH.

Footnotes
Studies and contributions from the Department of Internal Medicine, service of Dr. Cyrus C. Sturgis, and the Department of Dermatology and Syphilology, service of Dr. Udo J. Wile, University of Michigan Medical School.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?